Jove
Visualize
Contact Us

Related Experiment Videos

[Specific modulators of estrogen action].

A Guiochon-Mantel1

  • 1Inserm U 135, laboratoire d'hormonologie et biologie moléculaire, hôpital de Bicêtre, Le Kremlin, France.

Gynecologie, Obstetrique & Fertilite
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019).

Revue neurologique·2024
Same author

Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas.

European journal of neurology·2018
Same author

Targeted exomes reveal simultaneous MFN2 and GDAP1 mutations in a severe Charcot-Marie-Tooth disease type 2 phenotype.

European journal of neurology·2017
Same author

NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiency.

Clinical genetics·2016
Same author

SALL4 and NFATC2: two major actors of interstitial 20q13.2 duplication.

European journal of medical genetics·2014
Same author

Array comparative genomic hybridization analysis of small supernumerary marker chromosomes in human infertility.

Reproductive biomedicine online·2011
Same journal

[How I do… to see the sliding sign by transvaginal ultrasonography?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Cell-free fetal DNA screening tests for trisomy 21].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Lucy's cancer(s): A prehistorical origin?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Male age in assisted reproductive technologies: Is there a limit?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Iodinated contrast in pregnant women and neonatal thyroid function].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Breast cancer and diabetes mellitus: Complex interactions].

Gynecologie, obstetrique & fertilite·2016
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Selective estradiol receptor modulators (SERMs) offer targeted estrogenic or antiestrogenic effects. Advances in understanding estradiol action pave the way for designing novel therapeutic molecules.

Area of Science:

  • Endocrinology and Molecular Pharmacology
  • Estrogen Receptor Signaling Pathways

Context:

  • Selective estradiol receptor modulators (SERMs) are critical therapeutics targeting estrogen action.
  • Current understanding of estradiol's mechanism of action is rapidly evolving.
  • Key advancements include the discovery of ER beta, co-activators, and structural insights into receptor-ligand interactions.

Purpose:

  • To highlight recent scientific progress informing the design of new SERMs.
  • To underscore the importance of understanding estradiol receptor mechanisms.

Summary:

  • Recent progress in understanding estradiol action, including the cloning of ER beta and elucidation of co-activator mechanisms, is crucial.
  • Crystallization of the ligand-binding domain with agonists/antagonists provides molecular insights.

Related Experiment Videos

  • This knowledge facilitates the design of novel molecules with tailored estrogenic and antiestrogenic activities.

    • Impact:

    • Enables the development of next-generation SERMs with improved therapeutic profiles.
    • Advances the field of hormone-dependent disease treatment.
    • Provides a foundation for designing more selective and effective endocrine therapies.